The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The tyrosine kinase inhibitor, nilotinib potentiates a prothrombotic state

Published:2016-09 Issue: Volume:145 Page:54-64
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Alhawiti Naif,Burbury Kate L.,Kwa Faith A.,O'Malley Cindy J.,Shuttleworth Peter,Alzard Mohamad,Hamadi Abdullah,Grigg Andrew P.,Jackson Denise E.

Funder

Perpetual Trustees, Australia

King Saud bin Abdulaziz University-Health Sciences

Ministry of Higher Education

Publisher

Elsevier BV

Subject

Hematology

Reference40 articles.

1. STI-571:an anticancer protein-tyrosine kinases inhibitor;Roskoski;Biochem. Biophys. Res. Commun.,2003

2. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated chronic myeloid leukaemia: results of a phase II study;Talpaz;Blood,2002

3. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl;Weisberg;Cancer Cell,2005

4. Dasatinib in chronic myeloid leukaemia: a review;Aguilera;Ther. Clin. Risk Manag.,2009

5. Use of dasatinib and nilotinib in imatinib-resistant chronic myeloid leukaemia: translating preclinical findings to clinical practice;DeAngelo;Leukaemia and Lymphoma,2010

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

2. Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies;Current Treatment Options in Oncology;2024-06-12

3. Endothelial function in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors is not related to cardiovascular risk assessed by SCORE2 algorithm;Polish Archives of Internal Medicine;2024-04-03

4. Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management;Journal of Clinical Medicine;2024-03-09

5. Effect of chemotherapy in tumor on coronary arteries: Mechanisms and management;Life Sciences;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3